发明名称 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
摘要 A method for the prevention or reversal of transplant rejection, or for therapy for autoimmune diseases, is provided comprising administering compounds such as monoclonal antibodies, that bind specifically to one or more preselected CD45R leukocyte antigens, including the CD45RB epitope.
申请公布号 US6106834(A) 申请公布日期 2000.08.22
申请号 US19960715342 申请日期 1996.09.18
申请人 RESEARCH CORPORATION TECHNOLOGIES, INC. 发明人 LAZAROVITS, ANDREW I.;POPPEMA, SIBRAND
分类号 C12N15/09;A61K38/00;A61K39/395;A61P37/06;C07K16/28;C12P21/08;(IPC1-7):A61K39/395 主分类号 C12N15/09
代理机构 代理人
主权项
地址